SCHEMBL30006760

SCHEMBL30006760

O=c1oc2ccccc2c2oc3cc(O)ccc3c12

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.85
MAPT P10636 5/20 0.85
MEN1 O00255 4/20 0.85
RECQL P46063 4/20 0.85
KMT2A Q03164 4/20 0.85
ESR2 Q92731 4/20 0.85
HPGD P15428 3/20 0.85
BLM P54132 3/20 0.85
MAOA P21397 3/20 0.85
ALDH1A1 P00352 3/20 0.85
GAA P10253 2/20 0.85
ESR1 P03372 2/20 0.85
MGAM O43451 1/20 0.85
NR1I2 O75469 1/20 0.85
LMNA P02545 1/20 0.85
GLA P06280 1/20 0.85
POLB P06746 1/20 0.85
THRB P10828 1/20 0.85
CSNK2A2 P19784 1/20 0.85
CSNK2B P67870 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL234819 1.00 KDM4E (0.85) KDM4EMAPTMEN1RECQLKMT2A
SCHEMBL30004934 1.00 KDM4E (0.85) KDM4EMAPTMEN1RECQLKMT2A
SCHEMBL15870371 1.00 KDM4E (0.85) KDM4EMAPTMEN1RECQLKMT2A
Coumestrol SCHEMBL22012 0.92 ESR2 (1.00) KDM4EMAPTMEN1RECQLKMT2A
Coumestrol SCHEMBL29453366 0.92 ESR2 (1.00) KDM4EMAPTMEN1RECQLKMT2A
SCHEMBL15870374 0.88 ESR2 (0.84) KDM4EMAPTMEN1RECQLKMT2A
SCHEMBL15864245 0.85 KDM4E (0.70) KDM4EMAPTMEN1RECQLKMT2A
SCHEMBL30602583 0.85 KDM4E (0.70) KDM4EMAPTMEN1RECQLKMT2A
SCHEMBL30482848 0.85 KDM4E (0.70) KDM4EMAPTMEN1RECQLKMT2A
SCHEMBL14177143 0.84 ESR1 (0.82) KDM4EMAPTMEN1RECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260048025-A1 COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES NATURAL EXTRACTION SYS LLC (US) 2026-02-19 US disclosed
US-12409152-B2 Compositions and methods related to dissolved oxides Natural Extraction Systems, LLC (US) 2025-09-09 US disclosed
US-20220362169-A1 COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES Natural Extraction Systems, LLC 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12409152-B2 Compositions and methods related to dissolved oxides PRKG2, PRKG1, CIT KDM4E 4365/4885MAPT 2118/4885MEN1 593/4885
US-20260048025-A1 COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES SCO2, CNR2, CNR1 KDM4E 3795/4885MAPT 3552/4885MEN1 1906/4885
US-20220362169-A1 COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES PRKG2, PRKG1, CIT KDM4E 4365/4885MAPT 2118/4885MEN1 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.